Krys Boyd’s summer reading list - think.kera.org
4 days ago • Google News
Krystal Biotech Inc (KRYS)
US$ 165.69-2.47%
Price Chart
Key Statistics
Market Cap
$ 3.64B
P/E Ratio
30.21
Revenue (TTM)
$ 333.45M
Volume
253.27K
52W High
$ 219.34
52W Low
$ 122.80
Dividend Yield
0.00%
Beta
0.78
Technicals
50-Day MA
157.6709
200-Day MA
171.5485
52 Week High
219.34
52 Week Low
122.8
About KRYS
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United S.
Employees
275
Headquarters
Pittsburgh, PA
CEO
Mr. Krish S. Krishnan M.B.A., M.S.
Latest News
Krystal Biotech Enters Oversold Territory (KRYS) - Nasdaq
4 days ago • Google News
Jodi Kantor, Krys Boyd to headline Jamison Lecture | TWU - Texas Woman's University
2025-04-01 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg